The Immuno-Oncology Podcast

Special guest Shilpa Gupta, MD joins us to discuss the various ways to individually approach the adjuvant treatment setting for your patients with radically resected urothelial carcinoma along with their multidisciplinary care team. Dr. Gupta is a genitourinary oncologist at the Cleveland Clinic. Dr Gupta is a paid consultant of BMS. This podcast was sponsored by Bristol-Myers Squibb Company.

Special guest Jason Porter, MD joins once again to discuss these various options as well as the importance of a multidisciplinary tumor team in the treatment of resectable non-small cell lung cancer. Dr. Porter is a medical oncologist and hematologist at the West Cancer Center and Research Institute where he is the Director of the Lung Cancer disease research group. Dr. Porter is a paid consultant of BMS. This podcast was sponsored by Bristol Myers Squibb

Special guest Jason Porter, MD discusses how PD-L1 levels affected treatment outcomes in a clinical study for recurrent or metastatic non-small cell lung cancer. Dr. Porter is a medical oncologist and hematologist at the West Cancer Center and Research Institute where he is the Director of the Lung Cancer disease research group. Dr. Porter is a paid consultant of BMS. This podcast was sponsored by Bristol Myers Squibb.